Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Huttner
Stephan Harbarth

Showing results (11-20 of 501) with videos related to

Pageof 51
Sort By:
Evidence-Based Medicine|July 10, 2015
Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infectionsStephan Harbarth
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 20, 2007
[The effect of antimicrobial use on emergence and selection of resistance]Stephan Harbarth
Current Opinion in Critical Care|September 1, 2007
Should the development of new antibiotics be a public health priority?Stephan Harbarth
BMJ Open|July 16, 2017
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemiaAngela Huttner, Werner C Albrich, Pierre-Yves Bochud, et al.
Open Forum Infectious Diseases|November 29, 2023
Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs FosfomycinRebecca Grant, Andrea Büchler, William Flight, et al.
The Lancet. Infectious Diseases|December 5, 2018
Cefiderocol in contextAngela Huttner
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 7, 2022
Urinary tract infection: from intellectual dead end to exciting new frontier?Angela Huttner
The Lancet. Infectious Diseases|December 28, 2018
Cefiderocol for treatment of complicated urinary tract infections - Author's replyAngela Huttner
Infection Control and Hospital Epidemiology|October 9, 2010
Infection prevention research in Europe: recent advances and future prioritiesStephan Harbarth, Didier Pittet
Critical Care (London, England)|December 3, 2010
Year in review 2009: Critical Care--infectionStephan Harbarth, Thomas Haustein
Pageof 51

Showing results (11-20 of 501) with videos related to

Sort By:
Pageof 51
Evidence-Based Medicine|July 10, 2015
Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infectionsStephan Harbarth
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|February 20, 2007
[The effect of antimicrobial use on emergence and selection of resistance]Stephan Harbarth
Current Opinion in Critical Care|September 1, 2007
Should the development of new antibiotics be a public health priority?Stephan Harbarth
BMJ Open|July 16, 2017
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemiaAngela Huttner, Werner C Albrich, Pierre-Yves Bochud, et al.
Open Forum Infectious Diseases|November 29, 2023
Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs FosfomycinRebecca Grant, Andrea Büchler, William Flight, et al.
The Lancet. Infectious Diseases|December 5, 2018
Cefiderocol in contextAngela Huttner
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 7, 2022
Urinary tract infection: from intellectual dead end to exciting new frontier?Angela Huttner
The Lancet. Infectious Diseases|December 28, 2018
Cefiderocol for treatment of complicated urinary tract infections - Author's replyAngela Huttner
Infection Control and Hospital Epidemiology|October 9, 2010
Infection prevention research in Europe: recent advances and future prioritiesStephan Harbarth, Didier Pittet
Critical Care (London, England)|December 3, 2010
Year in review 2009: Critical Care--infectionStephan Harbarth, Thomas Haustein
Pageof 51